Therapeutic Classification: antidiabetics
Pharmacologic Classification: dipeptidyl peptidase-4 dpp-4 inhibitors, enzyme inhibitors
Absorption: 30% absorbed following oral administration.
Distribution: Extensively distributed to tissues.
Half-Life: >100 hr (due to saturable binding to DPP-4).
Contraindicated in:
Use Cautiously in:
CV: HF
Derm: bullous pemphigoid, localized exfoliation, urticaria
Endo: hypoglycemia
GI: ↑lipase, PANCREATITIS
MS: arthralgia, RHABDOMYOLYSIS
Resp: bronchial hyperreactivity
Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS, ANGIOEDEMA, AND EXFOLIATIVE SKIN CONDITIONS)
Drug-drug:
Lab Test Considerations: